ProJenX is a clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically defined pathways for the treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases
ProJenX is a clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically defined pathways for the treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.